Skip to main content

Positron Emission Tomography (PET) Market to Expand with Advancements in Cancer Imaging by 2030

 



The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in radiopharmaceuticals and PET systems; increasing demand for early and precise diagnosis; rising applications in oncology and neurology; and increasing investments, funds, and grants by public-private organizations are some of the key factors driving the PET market.

PET is a sophisticated imaging technique used primarily in medical diagnostics. It employs a radioactive substance known as a radiotracer, which is injected into the patient's bloodstream. As the radiotracer accumulates in tissues, it emits positrons that are detected by a PET scanner, creating detailed images of metabolic activity within the body. This allows healthcare providers to identify abnormalities such as tumors, assess heart function, and evaluate brain disorders. PET scans are particularly valuable for detecting diseases at early stages, often before they are visible through other imaging methods like CT or MRI scans.

🔗 Want deeper insights? Download the sample report:

https://meditechinsights.com/global-positron-emission-tomography-pet-market/request-sample/

Technological advancements in radiopharmaceuticals and PET systems to propel market demand

Technological advancements in radiopharmaceuticals are significantly driving the growth of the PET market. The development of novel radiotracers, such as Gallium-68 and Fluorine-18-labeled compounds, has expanded PET applications beyond oncology to neurology, cardiology, and infectious diseases. These advancements enhance diagnostic accuracy by targeting specific biomarkers, enabling early and precise disease detection. Improved radiotracer production technologies, such as automated synthesis systems and compact cyclotrons, ensure a steady supply of high-quality radiopharmaceuticals, even in remote areas. This progress supports the growing demand for PET imaging in personalized medicine, further boosting its adoption across healthcare systems globally.

Rising applications in oncology and neurology are driving the market growth

Rising applications in oncology and neurology are key drivers of the PET market. In oncology, PET is invaluable for detecting, staging, and monitoring various cancers, offering precise insights into tumor activity and treatment effectiveness. Radiotracers like FDG enable early cancer detection and help tailor therapies. In neurology, PET aids in diagnosing neurodegenerative disorders such as Alzheimer’s and Parkinson’s by visualizing brain metabolism and amyloid plaques. It also helps assess epilepsy and monitor responses to neurological treatments. These expanding applications highlight PET’s role in improving clinical outcomes, driving its adoption in advanced diagnostic and therapeutic practices.

Competitive Landscape Analysis

The global positron emission tomography (PET) market is marked by the presence of established and emerging market players such as GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., Oncovision, Positron, MinFound Medical Systems Co., Ltd, and CMR Naviscan; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Gain a competitive edge-request a sample report now! 

https://meditechinsights.com/global-positron-emission-tomography-pet-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global positron emission tomography (PET) market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, end user.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Standalone PET Systems
    • PET/CT Systems
      • Low-Slice Scanners
      • Medium-Slice Scanners
      • High-Slice Scanners
    • PET/MRI Systems
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Oncology
    • Neurology
    • Cardiology
    • Infectious Diseases
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more